139 related articles for article (PubMed ID: 12120912)
1. Serum beta 2-microglobulin reflects disease activity in Behçet's disease.
Aygündüz M; Bavbek N; Oztürk M; Kaftan O; Koşar A; Kirazli S
Rheumatol Int; 2002 May; 22(1):5-8. PubMed ID: 12120912
[TBL] [Abstract][Full Text] [Related]
2. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
3. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
[TBL] [Abstract][Full Text] [Related]
5. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
Icli A; Cure MC; Cure E; Arslan S; Unal M; Sakiz D; Ozucan M; Toker A; Turkmen K; Kucuk A
Acta Medica (Hradec Kralove); 2018; 61(3):86-92. PubMed ID: 30543512
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
Balkarli A; Kucuk A; Babur H; Erbasan F
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
8. Activation markers in Behçet's disease.
Coskun B; Saral Y; Gödekmerdan A; Erden I; Coskun N
Skinmed; 2005; 4(5):282-6. PubMed ID: 16282749
[TBL] [Abstract][Full Text] [Related]
9. The importance of serum interleukin-20 levels in patients with Behçet's disease.
Enecik ME; Mavi B; Yücel Ç; Keskin G; Yıldız M
Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054
[TBL] [Abstract][Full Text] [Related]
10. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
[TBL] [Abstract][Full Text] [Related]
11. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
12. Serum angiopoietin-1 level is increased in patients with Behçet's disease.
Choe JY; Park SH; Kim SK
Joint Bone Spine; 2010 Jul; 77(4):340-4. PubMed ID: 20471887
[TBL] [Abstract][Full Text] [Related]
13. Serum oxidant/antioxidant status in patients with Behçet's disease.
Taysi S; Kocer I; Memisogullari R; Kiziltunc A
Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
[TBL] [Abstract][Full Text] [Related]
14. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.
Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A
Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411
[TBL] [Abstract][Full Text] [Related]
16. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
[TBL] [Abstract][Full Text] [Related]
17. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
18. Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease.
Lee HJ; Shin HS; Jang HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Yonsei Med J; 2014 Jul; 55(4):960-6. PubMed ID: 24954324
[TBL] [Abstract][Full Text] [Related]
19. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
